Takahiro Wakasaki
Department Of Otolaryngology Head & Neck Surgery, 1-14-1 Miharadai, Minami Ku
Sakai, 5900197, Japan
Sakai, 5900197, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Epithelial tumors of the lacrimal drainage system: A narrative review.
Journal: Auris, nasus, larynx
Published: November 10, 2025
Impact of Multiple Primary Cancers on the Prognosis of Early-stage Oropharyngeal and Hypopharyngeal Squamous Cell Carcinoma: A Single-center Retrospective Study.
Journal: In vivo (Athens, Greece)
Published: August 10, 2025
Patterns of Recurrence and Malignant Transformation in Sinonasal Papilloma: Implications for Long-term Follow-up.
Journal: In vivo (Athens, Greece)
Published: July 21, 2025
The Role of Salvage Chemotherapy on Survival Outcomes Following Immune Checkpoint Inhibitor Therapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma.
Journal: In vivo (Athens, Greece)
Published: June 25, 2025
Prognostic Impact of Sarcopenia on Clinical Outcomes in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Treated With Immune Checkpoint Inhibitors.
Journal: Cancer diagnosis & prognosis
Published: May 21, 2025
Clinical analysis on sarcopenia according to the site of head and neck cancer.
Journal: Auris, nasus, larynx
Published: April 16, 2025
Pterygoid Muscle Necrosis Caused by Radiation and Intra-Arterial Cisplatin Infusion Chemotherapy (RADPLAT): A Case Report.
Journal: Case reports in oncology
Published: October 09, 2023
Acquired tracheobronchomalacia developed following voice prosthesis implantation.
Journal: Auris, nasus, larynx
Published: September 15, 2023
Lacrimal Sac Tumors: A Single-institution Experience, Including New Insights.
Journal: In vivo (Athens, Greece)
Published: January 31, 2023
Real-world Experience With Pembrolizumab for Advanced-stage Head and Neck Cancer Patients: A Retrospective, Multicenter Study.
Journal: Anticancer research
Published: April 29, 2022
Five-year Follow-up of Patients With Head and Neck Cancer Treated With Nivolumab and Long-term Responders for Over Two Years.
Journal: In vivo (Athens, Greece)
Published: March 27, 2022
Retrospective Study of Cisplatin/Carboplatin, 5-Fluorouracil Plus Cetuximab (EXTREME) for Advanced-stage Salivary Gland Cancer.
Journal: In vivo (Athens, Greece)
Published: December 22, 2021
Last Updated: 09/26/2026